Takeda approval ushers in new wave of sleep drugs

Reports

4

Domains carrying it

4

First reported

6 August 2026

Latest report

28 August 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 6 August 2026Takeda approval ushers in new wave of sleep drugsbiopharmadive.com
2. 19 August 2026FDA Approves First Drug to Treat a Cause of Narcolepsytime.com
3. 21 August 2026FDA Approves First Orexin Agonist for Narcolepsy Type 1ajmc.com
4. 28 August 2026Clinical Impacts of New FDA-Approved Oveporexton for Narcolepsy Type 1: Sara Sarkey, PhDneurologylive.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• FDA approves Takeda's first-in-class narcolepsy drug2 reports · 2 domains · 7 August 2026
• Lupin receives USFDA nod for sleep disorder treatment tablets2 reports · 2 domains · 5 September 2026
• US FDA approves Takeda, Protagonist's drug for rare blood cancer3 reports · 3 domains · 1 September 2026
• FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune ...11 reports · 11 domains · 1 September 2026
• FDA approves Ionis' antisense drug as first targeted therapy for Alexander disease12 reports · 12 domains · 5 September 2026
• U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ...12 reports · 12 domains · 17 August 2026

◆ Share

◆ Evidence

4 reports · 4 domains

• Clinical Impacts of New FDA-Approved Oveporexton for Narcolepsy Type 1: Sara Sarkey, PhDneurologylive.com · 28 August 2026
• FDA Approves First Orexin Agonist for Narcolepsy Type 1ajmc.com · 21 August 2026
• FDA Approves First Drug to Treat a Cause of Narcolepsytime.com · 19 August 2026
• Takeda approval ushers in new wave of sleep drugsbiopharmadive.com · 6 August 2026